ES458967A1 - Un procedimiento para la preparacion de una composicion de prostaglandina estabilizada. - Google Patents

Un procedimiento para la preparacion de una composicion de prostaglandina estabilizada.

Info

Publication number
ES458967A1
ES458967A1 ES458967A ES458967A ES458967A1 ES 458967 A1 ES458967 A1 ES 458967A1 ES 458967 A ES458967 A ES 458967A ES 458967 A ES458967 A ES 458967A ES 458967 A1 ES458967 A1 ES 458967A1
Authority
ES
Spain
Prior art keywords
preparation
stabilized
prostaglandin composition
composition
stabilized prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES458967A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of ES458967A1 publication Critical patent/ES458967A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Un procedimiento para la preparación de una composición de prostaglandina estabilizada que consiste en disolver un compuesto del grupo de a prostaglandina E en agua, en un disolvente orgánico o en una mezcla de los mismos, junto con lactato cálcico y/o amilopectina y secar la solución para formar un polvo seco.
ES458967A 1976-05-21 1977-05-19 Un procedimiento para la preparacion de una composicion de prostaglandina estabilizada. Expired ES458967A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51058702A JPS6043335B2 (ja) 1976-05-21 1976-05-21 安定なプロスタグランジンｅ類含有組成物

Publications (1)

Publication Number Publication Date
ES458967A1 true ES458967A1 (es) 1978-02-16

Family

ID=13091842

Family Applications (1)

Application Number Title Priority Date Filing Date
ES458967A Expired ES458967A1 (es) 1976-05-21 1977-05-19 Un procedimiento para la preparacion de una composicion de prostaglandina estabilizada.

Country Status (7)

Country Link
US (1) US4066787A (es)
JP (1) JPS6043335B2 (es)
BE (1) BE854865A (es)
DE (1) DE2719690A1 (es)
ES (1) ES458967A1 (es)
FR (1) FR2372625A1 (es)
GB (1) GB1582162A (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5391110A (en) * 1977-01-20 1978-08-10 Yamanouchi Pharmaceut Co Ltd Novel drug composition for rectal infusion
JPS6019740B2 (ja) * 1977-04-15 1985-05-17 東レ株式会社 プロスタグランジン熱安定化組成物
US4215117A (en) * 1978-05-26 1980-07-29 The Upjohn Company Stable pharmaceutical formulations
EP0056065B1 (de) * 1981-01-10 1984-04-04 CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. Stabilisierte, lokal anwendbare Prostaglandintabletten mit regulierter Auflösungsgeschwindigkeit und Verfahren zu der Herstellung
JPS57123113A (en) * 1981-01-16 1982-07-31 Chinoin Gyogyszer Es Vegyeszet Stable local prostaglandin tablet with appropriate even dissolution speed and manufacture
US4621100A (en) * 1981-09-25 1986-11-04 The Upjohn Company Treatment of osteoporosis with prostaglandins
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
JPH03220201A (ja) * 1988-11-18 1991-09-27 Eisai Co Ltd プロスタグランジン類と多糖類の結合体
GB8917470D0 (en) * 1989-07-31 1989-09-13 Quadrant Bioresources Ltd Composition and method
US5252602A (en) * 1991-10-11 1993-10-12 Rafeul Alam Effects of misoprostol on allergic responses
US5310759A (en) * 1992-08-12 1994-05-10 Bockman Richard S Methods of protecting and preserving connective and support tissues

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954787A (en) * 1974-06-18 1976-05-04 Pfizer Inc. Stabilized E-series prostaglandins

Also Published As

Publication number Publication date
FR2372625A1 (fr) 1978-06-30
US4066787A (en) 1978-01-03
JPS6043335B2 (ja) 1985-09-27
BE854865A (fr) 1977-11-21
DE2719690A1 (de) 1977-12-08
JPS52143217A (en) 1977-11-29
GB1582162A (en) 1980-12-31

Similar Documents

Publication Publication Date Title
AU502164B2 (en) Pharmaceutical composition containing 2, 6-diisopropylphenol
IL48423A0 (en) A heterocyclic compound,processes for the preparation thereof and pharmaceutical compositions containing the same
DK136075B (da) Analogifremgangsmåde til fremstilling af 11beta-hydroxy-16-methyl-3-oxo-17alfa-acyloxyandrosta-1,4,15-trien-17beta-carboxylater.
ES458967A1 (es) Un procedimiento para la preparacion de una composicion de prostaglandina estabilizada.
NL190539C (nl) Werkwijze ter bereiding van een stabiele doseringsvorm van een prostaglandine-achtige verbinding van het PGE-type, alsmede de met deze werkwijze verkregen capsules.
SE429237B (sv) Forfarande for framstellning av 9,3",4"-tri-alkanoyl sf-837 m,-derivat
NO160370C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.
JPS52108028A (en) Remedies for dysacousis
IL45136A0 (en) Process for the preparation of 3-(0,0-diethyldithiophosphorylmethyl)-6-chloro-benzoxazolone and insecticidal and acaricidal compositions containing same
IL49964A0 (en) 4-imino-1,3-diazobicyclo(3.1.0)hexan-2-one,processes for the preparation thereof and pharmaceutical compositions containing the same
MX3897E (es) Un procedimiento para la preparacion de composiciones insecticidas que contienen (6,7,8,9,10,10-hexacloro-1,5,5a,6,9,9a,-hexahidro-6,9-metano-2,4,3,-benzodioxatiepin-3-oxido)
HU171035B (hu) Insekticidy, akaricidy i nematocidy soderzhahhie proizvodnye tiazola i sposob poluchenija aktivnykh vehhestv
NO153951C (no) Fremgangsmaate for fremstilling av en farmasoeytisk tilberedning som inneholder 8-metoksy-furo-(3[ ,2[:6,7)-cumarin.
DK135167B (da) Analogifremgangsmåde til fremstilling af 7,7'-ditheophyllinderivater.
NO142789C (no) Fremgangsmaate for fremstilling av et polypeptidantibiotikum, gardimycin.
SE7505439L (sv) Forfarande for framstellning av 3-(5-nitroimidazol-2-yl)-pyrazolo 3,4-d -pyrimidinforeningar.
SE7708824L (sv) Forfarande for framstellning av 2,6-di-tert butylfenol
JPS52139789A (en) Method of preparing stable powder of neocarzinostatin
JPS5247984A (en) Stabilization of elastase
ES369815A1 (es) Procedimiento para la preparacion de 1 - ciano - 0 - carba-moil - formoximas sustituidas basicamente
CA1008451A (en) PROCESS FOR THE PREPARATION OF 2,2'-ANHYDRO-1.beta.-D-ARABINOFURANOSYL-5-FLUOROCYTOSINE
DK134408B (da) Analogifremgangsmåde til fremstilling af 3-oxo-17beta-n-amyloxyestra-4,9,11-trien.
AU7803675A (en) Process for the preparation of polymerisable, stable, organicdispersions
AU488718B2 (en) Pharmaceutical, composition
BE827643A (fr) Procede de preparation de l'hexanedione-2,5"